Details of the Drug
General Information of Drug (ID: DMLKK6Q)
Drug Name |
bromosporine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Bromosporine; 1619994-69-2; Bromorsporine; Bioomosporine; GTPL8234; SCHEMBL17359131; CHEMBL3133807; C17H20N6O4S; Bromosporine, > AOB6807; MolPort-035-395-798; HMS3653C21; KS-00000T5O; ZINC95616589; 2286AH; s7233; AKOS024458332; CS-3240; NCGC00351471-11; QC-10870; HY-15815; AK175193; A4186; SW219727-1; J3.656.836D; N-[(6-3-Methanesulfonamido-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate; ethyl (3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL is unavailable | 2D MOL | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||